JP2002533062A - Ｕｃｐ５ - Google Patents

Ｕｃｐ５

Info

Publication number
JP2002533062A
JP2002533062A JP2000585265A JP2000585265A JP2002533062A JP 2002533062 A JP2002533062 A JP 2002533062A JP 2000585265 A JP2000585265 A JP 2000585265A JP 2000585265 A JP2000585265 A JP 2000585265A JP 2002533062 A JP2002533062 A JP 2002533062A
Authority
JP
Japan
Prior art keywords
ucp5
polypeptide
seq
sequence
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000585265A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002533062A5 (https=
Inventor
アダムズ，ション
パン，ジェームズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of JP2002533062A publication Critical patent/JP2002533062A/ja
Publication of JP2002533062A5 publication Critical patent/JP2002533062A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2000585265A 1998-11-30 1999-11-03 Ｕｃｐ５ Pending JP2002533062A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US11028698P 1998-11-30 1998-11-30
US60/110,286 1998-11-30
US12958399P 1999-04-16 1999-04-16
US60/129,583 1999-04-16
US14388699P 1999-07-15 1999-07-15
US60/143,886 1999-07-15
PCT/US1999/025947 WO2000032624A2 (en) 1998-11-30 1999-11-03 Uncoupling protein 5 - ucp5

Publications (2)

Publication Number Publication Date
JP2002533062A true JP2002533062A (ja) 2002-10-08
JP2002533062A5 JP2002533062A5 (https=) 2010-04-22

Family

ID=27380826

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000585265A Pending JP2002533062A (ja) 1998-11-30 1999-11-03 Ｕｃｐ５

Country Status (8)

Country Link
US (2) US6967245B2 (https=)
EP (1) EP1135496B1 (https=)
JP (1) JP2002533062A (https=)
AT (1) ATE492640T1 (https=)
AU (1) AU774760B2 (https=)
CA (1) CA2349839C (https=)
DE (1) DE69943058D1 (https=)
WO (1) WO2000032624A2 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045438A1 (en) * 1997-04-09 1998-10-15 Beth Israel Deaconess Medical Center Ucp3: an uncoupling protein homologue

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775662A (en) 1983-03-07 1988-10-04 Smithkline Beckman Corporation Leukotriene antagonists
US5010003A (en) 1983-04-25 1991-04-23 Genentech, Inc. Use of yeast homologous signals to secrete heterologous proteins
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US5663304A (en) 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5407810A (en) 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
US5861485A (en) 1994-08-23 1999-01-19 Millennium Pharmaceuticals, Inc. Polypeptides involved in body weight disorders, including obesity
US6534631B1 (en) * 1998-07-15 2003-03-18 Human Genome Sciences, Inc. Secreted protein HT5GJ57
JP2002502240A (ja) 1997-05-20 2002-01-22 メルク エンド カンパニー インコーポレーテッド ヒト脱共役タンパク質３
WO2000004037A1 (en) 1998-07-14 2000-01-27 Amylin Pharmaceuticals, Inc. Uncoupling protein 4 (ucp-4) and methods of use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045438A1 (en) * 1997-04-09 1998-10-15 Beth Israel Deaconess Medical Center Ucp3: an uncoupling protein homologue

Also Published As

Publication number Publication date
CA2349839C (en) 2013-10-08
EP1135496B1 (en) 2010-12-22
AU1466700A (en) 2000-06-19
WO2000032624A3 (en) 2000-11-09
WO2000032624A2 (en) 2000-06-08
EP1135496A2 (en) 2001-09-26
DE69943058D1 (de) 2011-02-03
US20030077749A1 (en) 2003-04-24
US20080312417A1 (en) 2008-12-18
AU774760B2 (en) 2004-07-08
CA2349839A1 (en) 2000-06-08
US6967245B2 (en) 2005-11-22
ATE492640T1 (de) 2011-01-15

Similar Documents

Publication Publication Date Title
US20040018980A1 (en) Novel FIZZ proteins
JP2011155971A (ja) Ｉｌ−１関連ポリペプチド
IL205793A (en) Polymeric-2 Polymeric Polypeptide of Vertebrates Spotted to Heterologous Amino Acid Sequence
JP2002533122A5 (https=)
KR20010085816A (ko) 면역 관련 질환 치료용 조성물 및 치료 방법
AU2001271395B2 (en) Control of metabolism with compositions of the human 2-oxoglutarate carrier
US8313927B2 (en) Ucp4
US7342102B2 (en) Uncoupling protein 5 (UCP5)
US6967245B2 (en) Ucp5
US20080166763A1 (en) Human toll homologues
AU2001271395A1 (en) Control of metabolism with compositions of the human 2-oxoglutarate carrier
JP2002533062A5 (https=)
EP1209168B1 (en) PRO243 polypeptides and nucleic acids encoding the same
KR100721484B1 (ko) 사람의 퓨즈드 억제제와 관련된 핵산, 폴리펩티드 및 항체
ES2222959T3 (es) Polipeptidos pro241 y acido nucleico codificante de los mismos.
US20030087386A1 (en) Human toll homologue
EP1475439A2 (en) Control of metabolism with compositions of the human 2-oxoglutarate carrier

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090908

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091125

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091207

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20100308

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100525